Meningeal carcinomatosis in lung cancerJÄNNE, P. A; JANICEK, M. J; BROWN, F et al.Journal of clinical oncology. 2000, Vol 18, Num 15, pp 2926-2929, issn 0732-183XArticle

Chemoprevention of colorectal cancerJÄNNE, P. A; MAYER, R. J.The New England journal of medicine. 2000, Vol 342, Num 26, pp 1960-1968, issn 0028-4793Article

Case 2 : Acrometastasis as an initial presentation of non-small-cell lung carcinomaJÄNNE, P. A; DATTA, M. W; JOHNSON, B. E et al.Journal of clinical oncology. 1999, Vol 17, Num 9, pp 2998-3001, issn 0732-183XArticle

Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancerFLORES, L. M; KINDETBERGER, D. W; LIGON, A. H et al.British journal of cancer. 2010, Vol 102, Num 10, pp 1495-1502, issn 0007-0920, 8 p.Article

Mutations in the LKB I tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patientsKOIVUNEN, J. P; KIM, J; MEYERSON, M et al.British journal of cancer. 2008, Vol 99, Num 2, pp 245-252, issn 0007-0920, 8 p.Article

Physical mapping and genomic structure of the Lowe syndrome gene OCRL1NUSSBAUM, R. L; ORRISON, B. M; JÄNNE, P. A et al.Human genetics. 1997, Vol 99, Num 2, pp 145-150, issn 0340-6717Article

Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLCOU, S.-H. I; JÄNNE, P. A; RIELY, G. J et al.Annals of oncology. 2014, Vol 25, Num 2, pp 415-422, issn 0923-7534, 8 p.Article

Mapping of the 75-kDa inositol polyphosphate-5-phosphatase (Inpp5b) to distal mouse chromosome 4 and its exclusion as a candidate gene for dysgenetic lensJÄNNE, P. A; ROCHELLE, J. M; MARTIN-DELEON, P. A et al.Genomics (San Diego, Calif.). 1995, Vol 28, Num 2, pp 280-285, issn 0888-7543Article

Two ornithine decarboxylase nRNA species in mouse kidney arise from size heterogeneity at their 3' terminiHICKOK, N. J; SEPPÄNEN, P. J; KONTULA, K. K et al.Proceedings of the National Academy of Sciences of the United States of America. 1986, Vol 83, Num 3, pp 594-598, issn 0027-8424Article

EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patientsCAPPUZZO, F; FINOCCHIARO, G; DESTRO, A et al.Annals of oncology. 2008, Vol 19, Num 4, pp 717-723, issn 0923-7534, 7 p.Article

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patientsCAPPUZZO, F; VARELLA-GARCIA, M; HOLMES, A. J et al.British journal of cancer. 2008, Vol 99, Num 1, pp 83-89, issn 0007-0920, 7 p.Article

Screening for homologous recombination in ES cells using RT-PCRDANOFF, T. M; CHIANG, M; JÄNNE, P. A et al.BioTechniques. 1997, Vol 22, Num 1, pp 22-26, issn 0736-6205, 3 p.Article

Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitorERCAN, D; ZEJNULLAHU, K; KWIATKOWSKI, D. J et al.Oncogene (Basingstoke). 2010, Vol 29, Num 16, pp 2346-2356, issn 0950-9232, 11 p.Article

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patientsCAPPUZZO, F; JÄNNE, P. A; DESTRO, A et al.Annals of oncology. 2009, Vol 20, Num 2, pp 298-304, issn 0923-7534, 7 p.Article

Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancerTOSCHI, L; CAPPUZZO, F; JÄNNE, P. A et al.Annals of oncology. 2007, Vol 18, issn 0923-7534, ix150-ix155, SUP9Conference Paper

The oculocerebrorenal syndrome gene product is a 105-kD protein localized to the Golgi complexOLIVOS-GLANDER, I. M; JÄNNE, P. A; NUSSBAUM, R. L et al.American journal of human genetics. 1995, Vol 57, Num 4, pp 817-823, issn 0002-9297Article

Localization of the 75-kDa inositol polyphosphate-5-phosphatase (INPP5B) to human chromosome band 1p34JÄNNE, P. A; DUTRA, A. S; DRACOPOLI, N. C et al.Cytogenetics and cell genetics. 1994, Vol 66, Num 3, pp 164-166, issn 0301-0171Article

Isolation of a candidate gene for choroideremiaMERRY, D. E; JANNE, P. A; LANDERS, J. E et al.Proceedings of the National Academy of Sciences of the United States of America. 1992, Vol 89, Num 6, pp 2135-2139, issn 0027-8424Article

Combined effect of ALK and MEK inhibitors in EML4―ALK-positive non-small-cell lung cancer cellsTANIZAKI, J; OKAMOTO, I; NAKAGAWA, K et al.British journal of cancer. 2012, Vol 106, Num 4, pp 763-767, issn 0007-0920, 5 p.Article